INTRODUCTION
Agonist stimulation of a large variety of receptors in the central nervous system promotes hydrolysis of inositol phospholipids through activation of a phosphoinositide-specific phospholipase C [1, 2] . Phosphodiesteratic cleavage of PtdInsP2 by phospholipase C produces Ins(1,4,5)P, and sn-1,2-diacylglycerol, which release Ca2+ from intracellular stores and activate protein kinase(s) C (PKC) respectively [1] [2] [3] [4] . Metabolism of Ins (1, 4, 5) P3 is rapid and can follow two possible pathways (for review see [4] ). The simple dephosphorylation route proceeds by a 5-phosphatase, to Ins(1,4)P2, and Ins(1,3,4)P3/Ins(1,4)P2 I-phosphatase, to Ins4P. Alternatively, phosphorylation of Ins(1,4,5)P3 by 3- kinase generates the putative second messenger Ins(1,3,4,5)P4, which then undergoes sequential dephosphorylation via a 5-phosphatase, to Ins(1,3,4)P3, and either a 4-phosphatase or an Ins(1,3,4)P3/Ins(1,4)P2 1-phosphatase route to produce Ins(l,3)P2 and Ins(3,4)P2 respectively. Subsequent dephosphorylation produces InsIP and Ins3P, which along with Ins4P are metabolized by the inositol monophosphatase to release myo-inositol [4] . This complex pathway of Ins (1, 4, 5) P3 metabolism serves to terminate second-messenger action and to conserve efficiently the cellular myo-inositol pool for resynthesis of inositol phospholipids.
There is now substantial evidence that the anti-manic agent Li+ can disrupt the phosphoinositide cycle in brain and that this may be of importance in its therapeutic action [5, 6] . Li+ is a potent and uncompetitive inhibitor of the inositol monophosphatase enzyme (IC50 " 0.5 mM) [7, 8] , and to a lesser extent the Ins(1,3,4)P3/Ins(1,4)P2 I-phosphatase (IC50 5 mM) [9] .
Therapeutically relevant concentrations of Li+ (0.3-1.0 mM) have been shown to produce marked increases in the levels of inositol monophosphates and, by depriving phosphoinositide synthesis of a source of inositol, decreases in agonist-stimulated accumulations of Ins(1,4,5)P3 [10, 11] and Ins(1,3,4,5)P4 [10] [11] [12] [13] has been reported in rat and mouse cerebral-cortex slices.
In an attempt to analyse more fully the inositol phosphate metabolite proffile in Li+-treated cerebral cortex, we have observed a marked accumulation of a labelled bisphosphate which we had previously detected in this tissue as a very minor product after muscarinic-receptor stimulation and had tentatively identified as Ins(4,5)P2 [14] . The accumulation of this metabolite suggests an additional Li'-sensitive enzyme and an added complexity to inositol polyphosphate metabolism in cerebral tissue.
MATERIALS AND METHODS
Studies with I3Hlinositol-labelled brain slices Cerebral-cortex slices were prepared from male Wistar rats (250-300 g) as described previously [10] . In 
RESULTS

Effect of Li' on inositol bisphosphate isomer accumulation
In agreement with our previous studies in carbachol-stimulated cerebral-cortex slices [14] , four labelled bisphosphate products could be separated by h.p.l.c. (Fig. 1) . Identification of three of the metabolites as Ins(1,3)P2, Ins(1,4)P2 and Ins(3,4)P2 has been previously achieved by co-elution of standards and analysis of appropriate alditols [14] . The late-running minor peak had been tentatively identified as Ins(4,5)P2 [14] , and in these experiments support for this identification came from an identical elution of the alkaline phosphatase product of authentic [3H]Ins(1,4,5)P3 (Fig. 1) . The accumulation of each of the inositol bisphosphate products was increased upon muscarinic-receptor stimulation (47-, 4-, 12-and 23-fold respectively after 30 min), albeit from very different basal levels (Fig. 2) .
Li+ (10 /tM-10 mM) had either no effect, or a relatively weak The results in Fig. 3 demonstrate the time course of accumulation of inositol bisphosphate isomers in carbacholstimulated (1 mM) cerebral-cortex slices in the presence and Vol. 287 [10, 12] (Fig. 4) , which results from the potent uncompetitive inhibition of inositol monophosphatase [7, 8] . Thus it is tempting to suggest that Ins(4,5)P2 is generated in cerebral tissue after receptor activation and that it is metabolized by an enzyme that is potently inhibited by Li'. Indeed, the EC50 for Li+ enhancing its accumulation by carbachol (94 + 3 tM) could suggest a more potent inhibition than on the monophosphatase (however, see below 
